Clinical trial
Effect of Dialysate Flow Rate on Delivered Dose of Dialysis (Kt/Vurea)
NCT00962000 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Dialysate Flow Rate on Delivered Dose of Dialysis (Kt/Vurea)
- Lead sponsor
- Vantive Health LLC
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- June 30, 2010
- Enrollment
- 42 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease, chronic renal disease